H05BX02 • paricalcitol • Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents
Paricalcitol is a vitamin D analog used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It helps regulate calcium and phosphorus levels in the body, reducing excessive secretion of parathyroid hormone (PTH).
The medication is administered intravenously or orally, as directed by your doctor. It is important to monitor calcium, phosphorus, and PTH levels during treatment to prevent complications.
Side effects may include nausea, itching, hypercalcemia, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as bone or kidney diseases, to ensure the safe use of paricalcitol.
Substance: paricalcitol
Date of last drug list: 10-04-2026
Commercial code: W71089002
Concentration: 5mcg / ml
Pharmaceutical form: solution for injection
Quantity: 5
Product type: generic
Price: 177.64 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: RAFARM S.A. - GRECIA
Holder: HEATON K.S. - REPUBLICA CEHA
Number: 15954/2025/02
Shelf life: 2 years-after packaging for sale;after the first opening-a se utiliza imediat
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
177.64 RON
177.64 RON
0.00 RON
NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure
Price
Copayment
Patient
177.64 RON
177.64 RON
0.00 RON